The company said Friday it develops medicines designed to precisely target disease pathology with an initial emphasis on the innate immune system. Odyssey said its most advanced programs include ...
Jefferies analyst Stephen Volkmann maintained a Buy rating on Ingersoll Rand (IR – Research Report) yesterday and set a price target of ...
In a report released today, Inigo Vega from Jefferies reiterated a Buy rating on Nu Holdings (NU – Research Report). The company’s shares ...
Hosted on MSN19h
UnitedHealth Group Earnings Transcript (NYSE:UNH)Presentation Operator Good morning, and welcome to UnitedHealth Group Fourth Quarter and Full Year 2024 Earnings Conference ...
TOKYO: Japan's Nintendo said on Thursday it will release the Switch 2 console this year, unveiling a device that appeared to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback